PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-97.19%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-15.10%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
65.81%
Positive EBIT growth while ENPH is negative. John Neff might see a substantial edge in operational management.
53.01%
Positive operating income growth while ENPH is negative. John Neff might view this as a competitive edge in operations.
65.32%
Positive net income growth while ENPH is negative. John Neff might see a big relative performance advantage.
71.83%
Positive EPS growth while ENPH is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
71.83%
Positive diluted EPS growth while ENPH is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-71.98%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-72.01%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
No Data
No Data available this quarter, please select a different quarter.
82.45%
OCF growth above 1.5x ENPH's 38.79%. David Dodd would confirm a clear edge in underlying cash generation.
85.98%
FCF growth under 50% of ENPH's 172.07%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
-96.39%
Negative 10Y revenue/share CAGR while ENPH stands at 42.04%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-91.67%
Negative 5Y CAGR while ENPH stands at 109.35%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-88.57%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-124.40%
Negative 10Y OCF/share CAGR while ENPH stands at 256.95%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
90.42%
5Y OCF/share CAGR at 50-75% of ENPH's 129.58%. Martin Whitman would question if the firm lags in monetizing revenue effectively.
57.28%
Positive 3Y OCF/share CAGR while ENPH is negative. John Neff might see a big short-term edge in operational efficiency.
-136.70%
Negative 10Y net income/share CAGR while ENPH is at 19.83%. Joel Greenblatt sees a major red flag in long-term profit erosion.
69.14%
Positive 5Y CAGR while ENPH is negative. John Neff might view this as a strong mid-term relative advantage.
30.87%
Positive short-term CAGR while ENPH is negative. John Neff would see a clear advantage in near-term profit trajectory.
-118.50%
Negative equity/share CAGR over 10 years while ENPH stands at 686.48%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
14.22%
Below 50% of ENPH's 5101.52%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
-182.52%
Negative 3Y equity/share growth while ENPH is at 21.66%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-90.27%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-98.94%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-96.97%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-199.02%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-81.21%
We’re deleveraging while ENPH stands at 1.60%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-100.00%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-47.57%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.